Literature DB >> 10746983

Reversal effect of TTD on human multidrug resistant KBV200 cell line.

J Y Xu1, Q Zhou, P Shen, W Tang.   

Abstract

The reversal effect of TTD (a Chinese medicine) on human multidrug- resistant KBV200 cell line was studied and compared with verapamil (VPL). The chemosensitivity of KBV200 was detected by MTT assay in vitro and the level of MDR1 mRNA of KBV200 was investigated by RT-PCR. The cytotoxicity of TTD to KBV200 and the parent sensitive cell line KB is very low and nearly same with a concentration of 10(-6) mol x L(-1). With the concentration TTD increased VCR cytotoxicity on KBV200, 50% inhibitory concentration (IC50) decreased from 1122.5+/-72.36 mol x L(-1) to 31.76+/-5.4 nmol x L(-1) (p<0.001). It was more effective than VPL was (p<0.01). The combination of low concentration of TTD (10(-8) mol x L(-1)) and VCR (100 nmol x L(-1)) has significantly increased VCR cytotoxicity on KBV200, cell Surviving Fraction decreased from 0.91+/-0.056 to 0.74+/-0.07 (p<0.02). TTD did not inhibit the expression of MDR1 mRNA of KBV200 with the concentration of 10(-6) mol x L(-1). These data indicated that TTD could reverse VCR resistance of KBV200 and may be useful in enhancing the clinical effectiveness of VCR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10746983

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription.

Authors:  Huiling Shen; Wenlin Xu; Qiaoyun Chen; Zhaoyang Wu; Huarong Tang; Fachun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

2.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

3.  Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.

Authors:  Dan Liao; Wei Zhang; Pranav Gupta; Zi-Ning Lei; Jing-Quan Wang; Chao-Yun Cai; Albert A De Vera; Lei Zhang; Zhe-Sheng Chen; Dong-Hua Yang
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.